Abstract Background African American patients with bladder cancer have inferior outcomes
compared with non-Hispanic White (White) patients. We hypothesize that access to health …

Objective The military population may differ from the general population in factors related to
bladder and kidney cancers. However, incidence rates of these cancers have not been …

Objectives To assess contemporary gender, race and stage-specific incidence and trends of
bladder cancer among young adults in the United States. Materials and methods Within …

Background: Cancers comprise a significant proportion of urologic workload. The
epidemiology of prostate and renal cancers is well described. We report the incidence …

Purpose: To investigate the clinical management and outcome of patients with muscle-
invasive bladder cancer with clinical lymph node involvement, using longitudinal nationwide …

The past 25 years have witnessed an explosion of investigative attempts to identify clinically
useful biomarkers which can have meaningful impacts for patients with urologic cancers …

Bladder cancer (BC) is one of the top ten most common cancer types globally, accounting for
approximately 7% of all male malignancies. In the last few decades, cancer research has …

In 2022, the American Cancer Society projects an estimated 81 180 new cases of bladder
cancer (61 700 cases in men and 19 480 in women). 1 According to the National Cancer …

Renal cell carcinoma (RCC), alternative term for kidney cancer, is becoming more common
worldwide each year, and there are many different contributing factors. Among all cancers …

Results: Partial response was observed in 4 out of 9 (44%) patients with available imaging.
Common terminology criteria for adverse events (AE) grade 3 and 4 were observed in 3 out …